Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population
Context Jinlong capsule (JLC) is an animal-derived traditional Chinese medical preparation for advanced hepatocellular carcinoma (HCC). However, its clinical efficacy is still not well investigated. Objective This study summarizes the efficacy and safety of JLC combined with trans-arterial chemoembo...
Main Authors: | Shuzhao Jia, Ying Fu, Huimin Tao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Pharmaceutical Biology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13880209.2020.1799040 |
Similar Items
-
Efficacy, safety and tolerability of Tiger Balm® ointments: a systematic review and a meta-analysis of prevalence
by: Michele Antonelli, et al.
Published: (2020-01-01) -
Meta-analysis of Efficacy and Safety of Jinlong Capsule Combined with Chemoradiotherapy on Liver Metastases
by: KUANG Yuhui, et al.
Published: (2020-01-01) -
Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis
by: Chuihua Sun, et al.
Published: (2021-01-01) -
PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration
by: Xuan Zhang, et al.
Published: (2020-10-01) -
Efficacy of Xianglian pill for antibiotic-associated diarrhea: a protocol for systematic review and meta-analysis
by: Xin Zhou, et al.
Published: (2021-08-01)